Advertisement
Canada markets open in 7 hours 1 minute
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7331
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    84.02
    +0.45 (+0.54%)
     
  • Bitcoin CAD

    87,954.62
    +238.05 (+0.27%)
     
  • CMC Crypto 200

    1,391.91
    -4.63 (-0.33%)
     
  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,769.25
    +201.75 (+1.15%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Here's Why You Should Hold Global Life (GL) in Your Portfolio

Global Life Incorporation GL is well-poised for growth backed by higher premiums, strength at distribution channels and strong capital position.

The stock carries a VGM Score of B. VGM Score helps to identify stocks with the most attractive value, best growth and the most promising momentum.

Shares of this Zacks Rank #2 (Buy) have gained 38.4% year to date, outperforming the industry’s ralliy of 21.4%.

Estimates for Global Life have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for earnings for 2019 and 2020 have moved north by 0.6% and 0.3%, respectively, in the same time frame. The company beat estimates in the trailing four quarters by 1.53%, on average.

American Income Exclusive Agency, the most important distribution channel of Global life, contributes a major share of life premium and net sales. For the first nine months of 2019, this agency has witnessed a persistent increase in the life premiums. The operations at the Direct Response have also witnessed continuous growth in life premiums. The company remains focused on margin expansion instead of increasing sales.

Banking on solid cash flows, the company effectively deploys capital via share buybacks. In the first nine months of 2019, Global Life bought shares worth $273 million. Apart from this, the dividend has been increased at a five-year (2013-2018) CAGR of 4.7%. These endeavors make the stock an attractive pick for yield-seeking investors.

However, increased administrative expenses, pension costs and higher debt level are some of the headwinds plaguing Global Life currently.

The Zacks Consensus Estimate for 2019   earnings per share is pegged at $6.77, indicating an improvement of 10.4% from the year-ago reported figure. The expected long-term earnings growth rate is pegged at 8.1%.

Other Stocks to Consider

Investors interested in the finance sector can also take a look at some other top-ranked stocks like AXA Equitable Holdings Incorporation EQH, PRA Group, Incorporation PRAA and LendingClub Corporation LC, each carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

AXA Equitable Holdings Incorporation Holdings operates as a diversified financial services company worldwide. The company beat estimates in the trailing four quarters by 12.40%, on average.

PRA Group engages in the purchase, collection, and management of portfolios of nonperforming loans in the Americas and Europe. The company beat estimates in the trailing four quarters by 18.07%, on average.

Lending Club operates an online lending marketplace platform that connects borrowers and investors in the United States.  The company beat estimates in the trailing four quarters by 235.00%, on average.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
LendingClub Corporation (LC) : Free Stock Analysis Report
 
PRA Group, Inc. (PRAA) : Free Stock Analysis Report
 
Globe Life Inc. (GL) : Free Stock Analysis Report
 
AXA Equitable Holdings, Inc. (EQH) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research